Samsung Biologics Inks Deal to Mass-Produce COVID-19 Treatment
Samsung Biologics announced on Thursday that it signed with Vir Biotechnology Inc. a manufacturing agreement worth approximately $362 million (438 ...
Tag: Vir Biotechnology
No Result
View All Result
FREE NEWSLETTER
PRODUCTS
Most Popular
-
5 Best Korean to English Translation Apps
-
Top South Korean Tech Products to Look Out for in 2021
-
Top Eight Promising EdTech Startup Companies in South Korea
-
5 All-Time Best Rom-Com K-Dramas to Watch
-
Top Nine Mobile MMORPG in South Korea for 2020
-
Netmarble subsidiary Metaverse Entertainment’s K-Pop virtual girl band MAVE has a smashing online debut
-
World’s First 5G Robot Café has a Seoul Opening
-
Korean tech giants to focus on future innovations & sustainability actions at CES 2023
-
Top 10 Must-Have Korean Apps You Need When Visiting in Korea
-
South Korea Improves Digital New Deal with the Data Dam Project
Copyright © 2022 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : [email protected] |